Device approvals, stock buybacks & more — 5 GI company key notes

Here are five updates on GI companies from the past week:

The FDA approved Pentax's ED34-i10T, a duodenoscope with a disposable, single-use distal cap.

Allergan's board of directors authorized the company to buy back $2 billion in stock, while also committing to increasing its quarterly dividends and reaffirming its decision to pay down $3.75 billion in debt by 2018.

The FDA approved Bracco Diagnostics' Tagitol V oral suspension for adult patients undergoing virtual colonoscopy.

A study from England-based Oxford University further validated Medial EarlySign's ColonFlag.

Landos Biopharma completed a series A financing round raising $10 million.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast